Narwhal Capital Management - Q4 2022 holdings

$752 Million is the total value of Narwhal Capital Management's 161 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .

 Value Shares↓ Weighting
IVW  ISHARES TRs&p 500 grwt etf$3,276,000
+1.1%
56,0000.0%0.44%
-7.0%
DIA  SPDR DOW JONES INDL AVERAGEut ser 1$3,038,296
+15.3%
9,1700.0%0.40%
+5.8%
KMI  KINDER MORGAN INC DEL$2,741,832
+8.7%
151,6500.0%0.36%0.0%
XLK  SELECT SECTOR SPDR TRtechnology$2,620,458
+4.8%
21,0580.0%0.35%
-3.6%
BRKA  BERKSHIRE HATHAWAY INC DELcl a$2,343,555
+15.3%
50.0%0.31%
+6.1%
DVY  ISHARES TRselect divid etf$2,302,133
+12.5%
19,0890.0%0.31%
+3.4%
 HF SINCLAIR CORP$1,528,161
-3.6%
29,4500.0%0.20%
-11.7%
DAL  DELTA AIR LINES INC DEL$1,288,408
+17.1%
39,2090.0%0.17%
+7.5%
BHP  BHP GROUP LTDsponsored ads$1,206,873
+24.0%
19,4500.0%0.16%
+14.2%
ETR  ENTERGY CORP NEW$731,250
+11.8%
6,5000.0%0.10%
+2.1%
RIG  TRANSOCEAN LTD$592,800
+84.7%
130,0000.0%0.08%
+71.7%
BATRK  LIBERTY MEDIA CORP DEL$561,414
+17.2%
17,4190.0%0.08%
+8.7%
IWM  ISHARES TRrussell 2000 etf$563,183
+5.7%
3,2300.0%0.08%
-2.6%
VIS  VANGUARD WORLD FDSindustrial etf$511,942
+15.8%
2,8030.0%0.07%
+6.2%
IJH  ISHARES TRcore s&p mcp etf$505,550
+10.4%
2,0900.0%0.07%
+1.5%
EEM  ISHARES TRmsci emg mkt etf$464,275
+8.7%
12,2500.0%0.06%0.0%
VXF  VANGUARD INDEX FDSextend mkt etf$427,543
+4.5%
3,2180.0%0.06%
-3.4%
SPY  SPDR S&P 500 ETF TRtr unit$429,851
+7.2%
1,1240.0%0.06%
-1.7%
IYE  ISHARES TRu.s. energy etf$410,274
+18.2%
8,8250.0%0.06%
+10.0%
VUG  VANGUARD INDEX FDSgrowth etf$383,598
-0.4%
1,8000.0%0.05%
-8.9%
VGK  VANGUARD INTL EQUITY INDEX Fftse europe etf$358,174
+20.2%
6,4600.0%0.05%
+11.6%
VWO  VANGUARD INTL EQUITY INDEX Fftse emr mkt etf$280,266
+7.0%
7,1900.0%0.04%
-2.6%
VBK  VANGUARD INDEX FDSsml cp grw etf$270,729
+2.9%
1,3500.0%0.04%
-5.3%
IJJ  ISHARES TRs&p mc 400vl etf$252,000
+12.0%
2,5000.0%0.03%
+3.0%
NIM  NUVEEN SELECT MAT MUN FDsh ben int$90,600
+1.8%
10,0000.0%0.01%
-7.7%
XXII  22ND CENTY GROUP INC$14,038
+0.3%
15,2500.0%0.00%0.0%
ADAP  ADAPTIMMUNE THERAPEUTICS PLCsponds adr$15,102
+37.3%
10,3440.0%0.00%0.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-01-31
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VULCAN MATLS CO42Q3 202315.7%
ISHARES TR42Q3 20239.1%
APPLE INC42Q3 20236.5%
MICROSOFT CORP42Q3 20236.2%
JPMORGAN CHASE & CO42Q3 20232.9%
JOHNSON & JOHNSON42Q3 20232.1%
UNITEDHEALTH GROUP INC42Q3 20233.0%
PROCTER & GAMBLE CO42Q3 20232.1%
AMAZON COM INC42Q3 20233.6%
PFIZER INC42Q3 20232.1%

View Narwhal Capital Management's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-04-26
13F-HR2024-01-25
13F-HR2023-10-30
13F-HR2023-08-03
13F-HR2023-05-02
13F-HR2023-01-31
13F-HR2022-11-01
13F-HR2022-08-01
13F-HR2022-04-26
13F-HR2022-01-26

View Narwhal Capital Management's complete filings history.

Compare quarters

Export Narwhal Capital Management's holdings